ArticleMethods in molecular biology (Clifton, N.J.)2025
Quantification of RSV Antibodies in Human Plasma by Enzyme Immunoassays.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enzyme immunoassays (EIAs) to detect and quantify RSV IgG antibodies and RSV IgA antibodies in human plasma or sera are described. The first IgG EIA described uses RSV lysate antigens produced in the HEp-2 cell line to detect and quantify RSV IgG antibodies. The second IgG EIA uses the RSV F ectodomain secreted into the serum-free media of the 293-F expressing cell line for detecting antibodies against the RSV F protein. The third and fourth IgG EIAs use the media from 293-F cells expressing the ectodomain of RSV subgroup A G protein or subgroup B G protein to detect and quantify IgG antibodies in patient sera. The IgA EIA uses either the lysate antigens or the affinity-purified RSV F/G protein ectodomains expressed in 293-F cells, in serum-free media, for antibody detection. These EIAs have been characterized and evaluated for their ability to detect the respective RSV antibodies.
Indexed as
Identifiers
40879920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.